Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1081 of 6351
-
New antibody replacement therapy aims to shield vulnerable patients from serious infections
Disease control CompletedThe purpose of this study is to investigate the efficacy, safety, tolerability, and pharmacokinetic profile of the investigational medicinal product (IMP) and to determine, on the basis of historical control data, how it compares with other 10% intravenous immunoglobulin (IGIV) p…
Phase 3 • Sponsor: Evolve Biologics • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can adding immunotherapy to standard drugs fight resistant breast cancer?
Disease control OngoingThis research study is studying three combinations of drugs as treatments for breast cancer. The drugs involved in this study are: -Fulvestrant -Fulvestrant with Palbociclib -Fulvestrant with Palbociclib and Avelumab
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New drug combo aims to stop cancer return after transplant
Disease control OngoingThe investigators primary objective is to determine the safety and toxicity of incorporating blinatumomab into the post-allogeneic hematopoietic stem cell transplant (HSCT) maintenance setting for patients with CD19+-B-cell malignancies (Acute Lymphoblastic Leukemia \[ALL\], Non-…
Phase 1/2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Brain tumor patients may get a survival boost from targeted drug combo
Disease control OngoingThe Stupp protocol is the standard treatment of glioblastoma multiform (GBM) which prognosis remains poor. The non-dividing nature of normal brain cells provides an opportunity to enhance the therapeutic ratio by combining radiation with inhibitors of replication-specific DNA re…
Phase 1/2 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
A mesh shield: could a simple addition during surgery prevent painful hernias?
Prevention OngoingIt has been demonstrated that incisional hernia incidence after laparotomy can be safely reduced with the addition of a mesh to the conventional closure of the abdominal wall. There still some debate about which is the best position to place this mesh: onlay or sublay. In Europe …
Sponsor: Henares University Hospital • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC
-
Experimental combo targets Hard-to-Treat HPV cancers
Disease control OngoingThe study will consist of two parts : In the phase Ib: safety will be assessed in consecutive cohorts of 3 to 6 participants at increasing doses of TG4001 in combination with avelumab according to a 3+3 design. There will be no intra-participant dose escalation. In the phase II…
Phase 1/2 • Sponsor: Transgene • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Clean stoves for pregnant women may prevent low birth weight and pneumonia
Prevention CompletedThis study is a randomized controlled trial of liquefied petroleum gas (LPG) stove and fuel distribution in 3,200 households in four countries (India, Guatemala, Peru, and Rwanda). Following a common protocol, each intervention site will recruit 800 pregnant women (aged 18-34 yea…
Sponsor: Emory University • Aim: Prevention
Last updated Jun 27, 2026 12:31 UTC
-
Blood test may predict cure and detect resistance in B-Cell cancers
Diagnosis Recruiting nowThe study aims at assessing whether cell free DNA genotyping can improve the accuracy of early prediction of cure in mature B-cell tumor patients and whether it represents an accessible source of tumor DNA for the sensitive identification of genetic biomarkers that refine the dia…
Sponsor: Oncology Institute of Southern Switzerland • Aim: Diagnosis
Last updated Jul 11, 2026 00:00 UTC
-
Can a diet calm inflamed joints in children with arthritis?
Disease control OngoingThe aim of this study is to explore if an already established diet with anti-inflammatory effect in paediatric inflammatory bowel disease would have an anti-inflammatory effect in children with JIA. The diet is called specific carbohydrate diet.
Sponsor: Uppsala University • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Engineered immune cells take on tough blood cancers in early trial
Disease control OngoingThis phase I trial studies the side effects of CD19/CD22 chimeric antigen receptor (CAR) T cells when given together with chemotherapy and NKTR-255, and to see how well they work in treating patients with CD19 positive B acute lymphoblastic leukemia that has come back or does not…
Phase 1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Ultrasound program aims to halve stillbirths by spotting tiny babies earlier.
Prevention Recruiting nowFetal growth restriction during pregnancy represents one of the biggest risk factors for stillbirth (Gardosi et al, 2013), with 'about one in three term, normally formed antepartum stillbirths are related to abnormalities of fetal growth' (MBRRACE, 2015). Therefore, antenatal de…
Sponsor: Oxford University Hospitals NHS Trust • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
Could a pacemaker also treat high blood pressure? a new device aims to do both.
Disease control Stopped earlyThe purpose of this double blind randomized study is the evaluation of the safety and efficacy of the Moderato System. The Moderato implantable pulse generator is indicated for patients who have hypertension and also require a dual chamber pacemaker in order to reduce their blood…
Sponsor: BackBeat Medical Inc • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo shows promise for Hard-to-Treat breast cancer
Disease control CompletedThis was a Phase II, multicenter, open-label, three-cohort, non-comparative study of alpelisib plus endocrine therapy (either fulvestrant or letrozole) in subjects (pre- and post-menopausal women and men) with HR-positive, HER2-negative aBC harboring PIK3CA mutation(s) in the tum…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New hope for kids with rare liver tumors: tailored therapy trial shows promise
Disease control OngoingThe PHITT trial is an over-arching study for patients with Hepatoblastoma (HB) and Hepatocellular Carcinoma (HCC). This trial will use a risk-adapted approach to the treatment of children diagnosed with HB. Children with HCC will be included as a separate cohort.
Phase 3 • Sponsor: University of Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can a 7-Week brain tumor treatment beat the standard 10-Week plan?
Disease control CompletedThe investigators of this study want to see if shortening the total treatment time for brain tumors is safe.The treatment for participant's brain tumors is laser surgery (Laser Interstitial Thermal Therapy (LITT)) followed by radiation with chemotherapy. For participants, the tot…
Early phase 1 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Triple threat: new combo aims to tame metastatic prostate cancer
Disease control OngoingThis is a study with the combination of androgen deprivation therapy (ADT) and docetaxel with the addition of enzalutamide in the treatment of subjects with metastatic prostate cancer. The purpose of this study is to assess if ADT + docetaxel + enzalutamide is well tolerated and …
Phase 2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New hope for kids with rare cancers: targeted drug larotrectinib tested in small trial
Disease control OngoingThis phase II Pediatric MATCH trial studies how well larotrectinib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with NTRK fusions that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of th…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New heart valve fix could spare thousands from Open-Heart surgery
Disease control OngoingTo demonstrate the safety and effectiveness of the Edwards Alterra Adaptive Prestent in conjunction with the Edwards SAPIEN 3 Transcatheter Heart Valve (THV) System in subjects with a dysfunctional right ventricular outflow tract/pulmonary valve (RVOT/PV) who are indicated for tr…
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Precision drug shows promise for rare Gene-Driven cancers
Disease control OngoingThis phase II MATCH treatment trial tests how well larotrectinib (LOXO-101) works in treating patients with cancer that has certain genetic changes. Larotrectinib (LOXO-101) is used in patients whose cancer has a mutated (changed) form of a gene called NTRK. It is in a class of m…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New polio vaccine shows promise in large infant trial
Vaccine CompletedThe study aimed to evaluate the safety and immunogenicity of a Sabin strain-based inactivated polio vaccine in infants aged two months (60\~89 days).
Phase 3 • Sponsor: Beijing Minhai Biotechnology Co., Ltd • Aim: Vaccine
Last updated Jun 27, 2026 08:06 UTC